The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2016

Filed:

Sep. 15, 2014
Applicant:

Cadila Healthcare Limited, Ahmedabad, Gujarat, IN;

Inventors:

Reinhard Glueck, Gujarat, IN;

Agata Fazio, Catania, IT;

Viviana Gianino, Catania, IT;

Martin A. Billeter, Zurich, CH;

Assignee:

Cadila Healthcare Limited, Ahmedabad, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); A61K 39/165 (2006.01); A61K 38/20 (2006.01); A61K 39/00 (2006.01); A61K 39/015 (2006.01); A61K 39/12 (2006.01); C12N 7/00 (2006.01); A61K 35/13 (2015.01);
U.S. Cl.
CPC ...
A61K 39/165 (2013.01); A61K 38/2013 (2013.01); A61K 39/0015 (2013.01); A61K 39/015 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 35/13 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/55588 (2013.01); A61K 2039/575 (2013.01); A61K 2039/70 (2013.01); C12N 2760/18421 (2013.01); C12N 2760/18434 (2013.01); C12N 2760/18442 (2013.01); C12N 2760/18443 (2013.01);
Abstract

A combined measles-malaria vaccine containing different attenuated recombinant measles-malaria vectors comprising a heterologous nucleic acid encoding severalantigens is described. Preferably, it relates to viral vectors that comprise nucleic acids encoding the circumsporozoite (CS) protein of, the merozoite surface protein 1 (MSP-1) of, and its derivatives (p-42; p-83-30-38) in its glycosylated and secreted forms, and apical membrane antigen1 (AMA1) of, in its anchored or secreted form. The viral vector stems from an attenuated measles virus, based on a strain that is used as a vaccine and is efficient in delivering the gene of interest and that binds to and infects the relevant immune cells efficiently.


Find Patent Forward Citations

Loading…